Bovine papillomavirus and cancer

Veterinary Journal

Volumn 154, Issue 3, 1997, Pages 175-188

  Campo, M S ^a  

^a BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

Cancer; Cell transformation; Cofactors; Papillomavirus; Vaccination

Indexed keywords

VIRUS PROTEIN; VIRUS VACCINE;

ANIMAL; ANIMAL DISEASE; BLADDER TUMOR; BOVINE PAPILLOMAVIRUS 1; BOVINE PAPILLOMAVIRUS 4; CATTLE; CATTLE DISEASE; CELL TRANSFORMATION; GASTROINTESTINAL TUMOR; GENETICS; IMMUNOLOGY; PAPILLOMA; PATHOLOGY; PHYSIOLOGY; REVIEW; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; VIRUS GENOME; VIRUS INFECTION;

ANIMALS; BOVINE PAPILLOMAVIRUS 1; BOVINE PAPILLOMAVIRUS 4; CARCINOMA, SQUAMOUS CELL; CATTLE; CATTLE DISEASES; CELL TRANSFORMATION, NEOPLASTIC; GASTROINTESTINAL NEOPLASMS; GENOME, VIRAL; PAPILLOMA; PAPILLOMAVIRUS INFECTIONS; SKIN NEOPLASMS; TUMOR VIRUS INFECTIONS; URINARY BLADDER NEOPLASMS; VIRAL PROTEINS; VIRAL VACCINES;

EID: 0031264595     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1090-0233(97)80019-6     Document Type: Review

References (96)

1. ALONSO-AMELOT, M. E., CASTILLO, U, SMITH, B. L. & LAUREN, D. R. (1996). Bracken ptaquiloside in milk. Nature 382, 587.
2. ANDERSON, R. A., SCOBIE, L., O'NEIL, B. W., GRINDLAY, G. J. & CAMPO, M. S. (1997). Viral proteins of bovine papillomavirus type 4 during the development of alimentary canal tumours. The Veterinary Journal 154, 69-78.
3. ANTINORE, M. J., BIRRER, M. J., PATEL, D., NADER, L. & MCCANCE, D. J. (1996). The human papillomavirus type 16 E7 gene product interacts with and trans-activates the AP-1 family of transcription factors. EMBO Journal 15, 1950-60.
4. ANWAR, K., NAIKI, H., NAKAKUKI, K. & INUZUKA, M. (1992). High frequency of human papillomavirus infection in carcinoma of the urinary bladder. Cancer 70, 1967-73.
5. BANKS, L. & MATLASHEWSKI, G. (1993). Cell transformation and the HPV E5 gene. Papillomavirus Report 4, 1-4.
6. BENTON, C., SHAHIDULLAH, H. & HUNTER, J. A. A. (1992). Human papillomavirus in the immunosuppressed. Papillomavirus Report 3, 23-6.
7. BERNARD, B. A., BAILLY, C., LENOIR, M. C., DARMON, M., THIERRY, F. & YANIV, M. (1989). The human papillomavirus type 18 (HPV18) E2 gene product is a repressor of the HPV18 regulatory region in human keratinocytes. Journal of Virology 63, 4317-24.
8. BORYSIEWICZ, L. K., FLANDER, A., NIMAKO, M., MAN, S., WILKINSON, G. W. G., WESTMORELAND, D., EVANS, A. S., ADAMS, A. S., STACEY, S. N., BOURSNELL, M. E. G., RUTHERFORD, E., HICKLING, J. K. & INGLIS, S. C. (1996). A recombinant vaccinia virus encoding human papillomavirus type 16 and 18 E6 and E7 proteins as immunotherapy for cervical cancer. The Lancet 347, 1523-7.
9. BOTCHAN, M., BERG, L., REYNOLDS, J. & LUSKY, M. (1986). The bovine papillomavirus replicon. In Papillomaviruses, pp. 53-67. eds D. Evered and S. Clark. John Wiley & Sons, Chichester, UK.
10. BUNNEY, M. H., BARR, B. B., MCLAREN, K., SMITH, I. W., BENTON, E. C., ANDERTON, J. L. & HUNTER, J. A. A. (1987). Human papillomavirus type 5 and skin cancer in renal allograft recipients. The Lancet ii, 151-2.
11. CAIRNEY, M. & CAMPO, M. S. (1995). The synergism between bovine papillomavirus type 4 and quercetin is dependent on the timing of exposure. Carcinogenesis 16, 1997-2001.
12. CAMPO, M. S. (1992). Cell transformation by animal papillomaviruses. Journal of General Virology 73, 217-22.
13. CAMPO, M. S. (1995). Infection by bovine papillomavirus and prospects for vaccination. Trends in Microbiology 3, 92-7.
14. CAMPO, M. S. & JARRETT, W. F. H. (1994). Vaccination against cutaneous and mucosal papillomavirus in cattle. In Vaccines against virally induced cancers. Ciba Foundation Symposium 187, 61-77.
15. CAMPO, M. S., MOAR, M. H., SARTIRANA, M. L., KENNEDY, I. M. & JARRETT, W. F. H. (1985). The presence of bovine papillomavirus type 4 DNA is not required for the progression to, or maintenance of, the malignant state in cancers of the alimentary canal in cattle. EMBO Journal 4, 1819-25.
16. CAMPO, M. S., MCCAFFERY, R. E., DOHERTY, I., KENNEDY, I. M. & JARRETT, W. F. H. (1990). The Harvey ras 1 gene is activated in papillomavirus associated carcinomas of the upper alimentary canal in cattle. Oncogene 5, 303-8.
17. CAMPO, M. S., JARRETT, W. F. H., BARRON, R., O'NEIL, B. W. & SMITH, K. T. (1992). Association of bovine papillomavirus type 2 and bracken fern with bladder cancer in cattle. Cancer Research 52, 6898-904.
18. CAMPO, M. S., GRINDLAY, G. J., O'NEIL, B. W., CHANDRACHUD, L. M., MCGARVIE, G. M. & JARRETT, W. F. H. (1993). Prophylactic and therapeutic vaccination against a mucosal papillomavirus. Journal of General Virology 74, 945-53.
19. CAMPO, M. S., O'NEIL, B. W., BARRON, R. J. & JARRETT, W. F. H. (1994a). Experimental reproduction of the papilloma-carcinoma complex of the alimentary canal in cattle. Carcinogenesis 15, 1597-601.
20. CAMPO, M. S., JARRETT, W. F. H., O'NEIL, B. W. & BARRON, R. J. (1994b). Latent papillomavirus infection in cattle. Research in Veterinary Science 56, 151-7.
21. CHANDRACHUD, L. M., O'NEIL, B. W., JARRETT, W. H. F., GRINDLAY, G. J., MCGARVIE, G. M. & CAMPO, M. S. (1994). Humoral immune response to the E7 protein of bovine papillomavirus type 4 and identification of B-cell epitopes. Virology 200, 98-104.
22. CHANDRACHUD, L. M., GRINDLAY, G. J., MCGARVIE, G. M., O'NEIL, B. W., WAGNER, E. R., JARRETT, W. F. H. & CAMPO, M. S. (1995). Vaccination of cattle with the N-terminus of L2 is necessary and sufficient for preventing infection by bovine papillomavirus type 4. Virology 211, 204-8.
23. CHANEDEAU, C., HAY, K., HIRTE, H. W., GALLINGER, S. & BACCHETTI, S. (1995). Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Research 55, 2533-6.
24. CHANG, F., SYRJANEN, S., SHEN, Q., JI, H. & SYRJANEN, K. (1990). Human papillomavirus DNA in esophageal precancer lesions and squamous cell carcinomas from China. International Journal of Cancer 45, 21-5.
25. CHEN, L., THOMAS, E. K., HU, S. L., HELLSTROM, I. & HELLSTROM, K. E. (1991). Human papillomavirus type 16 nucleoprotein E7 is a tumour rejection antigen. Proceedings of the National Academy of Science 88, 110-4.
26. CHRISTENSEN, N. D., KREIDER, J. W., KAN, N. C. & DIANGELO, S. L. (1991). The open reading frame L2 of cottontail rabbit papillomavirus contains antibody-inducing neutralising epitopes. Virology 181, 572-9.
27. COHEN, B. D., GOLDSTEIN, D. J., RUTLEDGE, L., VASS, W. C., LOWY, D. R., SCHLEGEL, R. & SCHILLER, J. T. (1993). Transformation-specific interaction of the bovine papillomavirus E5 oncoprotein with platelet-derived growth factor receptor transmembrane domain and the epidermal growth factor receptor cytoplasmic domain. Journal of Virology 67, 5303-11.
28. COLEMAN, N., BIRLEY, H. D. L., RENTON, A. M., HANNA, N. F., RYAIT, B. K., BYRNE, M., TAYLOR-ROBINSON, D. & STANLEY, M. A. (1994). Immunological events in regressing genital warts. American Journal of Clinical Pathology 102, 768-74.
29. DOORBAR, J. (1991). An emerging function for E4. Papillomavirus Report 2, 145-7.
30. EVANS, I. A., PROROK, J. H., COLE, R. C., AL-SAMANI, M. H., AL-SAMARRI, A. M., PATEL, M. C. & SMITH, R. M. N. (1982). The carcinogenic, mutagenic and teratogenic toxicity of bracken. Proceedings of The Royal Society of Edinburgh 81, 65-77.
31. EVANS, W. C., PATEL, M. C. & KOOHY, Y. (1982). Acute bracken poisoning in homogastric and ruminant animals. Proceedings of the Royal Society of Edinburgh 81, 29-64.
32. FACCINI, A. M., CAIRNEY, M., ASHRAFI, G. H., FINBOW, M. E., CAMPO, M. S. & PITTS, J. D. (1996). The bovine papillomavirus type 4 E8 protein binds to ductin (16kDa) and causes loss of gap junction intercellular communication in primary fibroblasts. Journal of General Virology 70, 9041-5.
33. FINBOW, M. E., PITTS, J. D., GOLDSTEIN, D. J., SCHLEGEL, R. & FINDLAY, J. B. C. (1991). The E5 oncoprotein target: a 16kDa channel-forming protein with diverse functions. Molecular Carcinogenesis 4, 441-4.
34. GALPIN, O. P., WHITAKER, C. J., WHITAKER, R. H. & KASSAB, J. Y. (1990). Gastric cancer in Gwynedd. Possible links with bracken. British Journal of Cancer 61, 737-40.
35. GAUKROGER, J. M., CHANDRACHUD, L. M., O'NEIL, B. W., GRINDLAY, G. J., KNOWLES, G. & CAMPO, M. S. (1996). Vaccination of cattle with bovine papillomavirus type 4 L2 elicits the production of virus-neutralizing antibodies. Journal of General Virology 77, 1577-83.
36. GOLDSTEIN, D. J., ANDRESSON, T., SPARKOWSKI, J. J. & SCHLEGEL, R. (1992). The BPV-1 E5 protein, the 16kDa membrane pore-forming protein and the PGDF receptor exist in a complex that is dependent on hydrophobic transmembrane interactions. EMBO Journal 11, 4851-9.
37. HOLDER, J. W., ELMORE, E. & BARRETT, J. C. (1993). Gap junction function and cancer. Cancer Research 53, 3475-85.
38. HOPPE-SEYLER, & BUTZ, K. (1994). Cellular control of human papillomavirus oncogene transcription. Molecular Carcinogenesis 10, 134-41.
39. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans (1995), vol 64: Human Papillomavirus. IARC, Lyon, France.
40. IFTNER, T., SAGNER, G., PFISTER, H. & WETTSTEIN, F. O. (1990). The E7 protein of human papillomavirus 8 is a nonphosphorylated protein of 17kD and can be generated by two different mechanisms. Virology 179, 248-436.
41. JACKSON, M. E. & CAMPO, M. S. (1995). Both viral E2 protein and the cellular factor PEBP2 regulate transcription via E2 consensus sites within the bovine papillomavirus type 4 long control region. Journal of Virology 69, 6038-46.
42. JACKSON, M. E. & CAMPO, M. S. (1991). Positive and negative E2-independent regulatory elements in the long control region of bovine papillomavirus type 4. Journal of General Virology 72, 877-83.
43. JACKSON, M. E., CAMPO, M. S. & GAUKROGER, J. (1993). Cooperation between papillomavirus and chemical cofactors in oncogenesis. Clinical Reviews in Oncogenesis 4, 277-91.
44. JACKSON, M. E., PENNIE, W. D., MCCAFFERY, R. E., SMITH, K. T., GRINDLAY, G. J. & CAMPO, M. S. (1991). The B sub-group bovine papillomavirus lack an identifiable E6 open reading frame. Molecular Carcinogenesis 4, 382-7.
45. JAGGAR, R. T., PENNIE, W. D., SMITH, K. T., JACKSON, M. E. & CAMPO, M. S. (1990). Cooperation between bovine papillomavirus type 4 and ras in the morphological transformation of primary bovine fibroblasts. Journal of General Virology 71, 3041-6.
46. JARRETT, W. F. H., CAMPO, M. S., O'NEIL, B. W., LAIRD, H. M. & COGGINS, L. W. (1984). A novel bovine papillomavirus (BPV6) causing true epithelial papillomas of the mammary gland skin: a member of a proposed new BPV subgroup. Virology 136, 255-64.
47. JARRETT, W. F. H., MCNEIL, P. E., GRIMSHAW, W. T. R., SELMAN, I. E. & MCINTYRE, W. I. M. (1978). High incidence area of cattle cancer with a possible interaction between an environmental carcinogen and a papilloma virus. Nature 274, 215-7.
48. JARRETT, W. F. H. (1985). The natural history of bovine papillomavirus infections. Advances in Viral Oncology 5, 83-102.
49. KEDZIA, H., GOZDZICKA-JOZEFIAK, A., WOLNA, M. & TOMCZAK, E. (1992). Distribution of human papillomavirus 16 in the blood of women with uterine cervix carcinoma. European Journal of Gynaecological Oncology 6, 522-6.
50. KIRNBAUER, R., CHANDRACHUD, L. M., O'NEIL, B. W., WAGNER, E. R., GRINDLAY, G. J., ARMSTRONG, A., MCGARVIE, G. M., SCHILLER, J. T., LOWY, D. R. & CAMPO, M. S. (1996). Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization. Virology 218, 37-44.
51. KLINGELHUTZ, A. J., FOSTER, S. C. & MCDOUGALL, J. K. (1996). Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 380, 79-82.
52. KNOWLES, G., O'NEIL, B. W. & CAMPO, M. S. (1996). Phenotypical characterization of lymphocytes infiltrating regressing papillomas. Journal of Virology 70, 6451-8.
53. KNOWLES, G., GRINDLAY, G. J., CAMPO, M. S., CHAUDOACHUD, L. M. and O'NEIL, B. W. (1997). linear B-cell epitopes in the N-Terminus of L2 of bovine papillomavirus Type 4. Research in Veterinary Science 62, 289-91.
54. KREIDER, J. W. & BARTLETT, G. L. (1985). Shope rabbit papilloma-carcinoma complex. Clinics in Dermatology 3, 20-6.
55. LAMBERT, P. F., SPALHOLZ, B. A. & HOWLEY, P. M. (1987). A transcriptional repressor encoded by BPV1 shares a common C-terminus with the E2 transactivator. Cell 50, 69-78.
56. LAMBERT, P. F. (1991). Papillomavirus DNA replication. Journal of Virology 65, 3417-20.
57. LEES, E., OSBORN, K., BANKS, L. & CRAWFORD, L. (1990). Transformation of primary BRK cells by human papillomavirus type 16 and EJ-ras is increased by overexpression of the viral E2 protein. Journal of General Virology 71, 183-93.
58. LEVY, M. Z., ALLSOP, R. C., FUTCHER, A. B., GREIDER, C. W. & HARLEY, C. B. (1992). Telomere end-replication problem and cell ageing. Journal of Molecular Biology 225, 951-60.
59. LIN, Y. L., BORENSTEIN, L. A., SELVAKUMAR, R., AHMED, R. & WETTSTEIN, F. O. (1992). Effective vaccination against papilloma development by immunisation with L1 or L2 structural proteins of cottontail rabbit papillomavirus. Virology 187, 612-9.
60. LINDEBERG, H., OSTER, S., OXLUND, I. & ELBROND, O. (1986). Laryngeal papillomas: classification and course. Clinical Otolaryngology 11, 423-9.
61. MARLIERE, C. A., SANTOS, R. C., GALVAO, M. A. M., SILVA, M. L. C., KAWAMOTO, M., CASTRO, M. C. F. M., SOARES, J. F., VON KRUGER, E. R., BARRETO, J. M. A. & GOMES, R. Q. F. (1994). Gastric and oesophageal cancer related to bracken ingestion: a case-control study from Ouro Preto, Minas Gerais, Brazil. In Bracken: an environmental issue, pp. 99-101. eds R. T. Smith and J. A. Taylor. The International Brocken Group, Aberystwyth, UK.
62. MASSIMI, P., DIM, D., STOREY, A. & BANKS, L. (1996). HPV-16 E7 and adenovirus E1a complex formation with TATA box binding protein is enhanced by casein kinase II phosphorylation. Oncogene 12, 2325-30.
63. MCCAFFERY, R. E. & JACKSON, M. E. (1994). An element binding a C/EBP-related transcription factor contributes to the negative regulation of the bovine papillomavirus type 4 long control region. Journal of General Virology 75, 3047-56.
64. MCGARVIE, G. M., GRINDLAY, G. J., CHANDRACHUD, L. M., O'NEIL, B. W., JARRETT, W. F. H. & CAMPO, M. S. (1995). T cell responses to BPV-4 E7 during infection and mapping of T cell epitopes. Virology 206, 504-10.
65. MCLEAN, C. S., STERLING, J. S., MOWAT, J., NASH, A. A. & STANLEY, M. A. (1993). Delayed type hypersensitivity response to the human papillomavirus type 16 protein in a mouse model. Journal of General Virology 74, 239-45.
66. MENEGUZZI, G., CERNI, C., KIENY, M. P. & LATHE, R. (1991). Immunisation against human papillomavirus type 16 tumour cells with recombinant vaccinia viruses expressing E6 and E7. Virology 181, 62-9.
67. MOURA, J. W., STOCCO DOS SANTOS, R. C., DAGLI, M. L. Z., D'ANGELINO, J. L., BIRGEL, E. H. & BECAK, W. (1988). Chromosome aberrations in cattle raised on bracken fern pasture. Experientia 44, 785-8.
68. OELZE, I., KARTENBECK, J., CRUSIUS, K. & ALONSO, A. (1995). Human papillomavirus type 16 E5 protein affects cell-cell communication in an epithelial cell line. Journal of Virology 69, 4489-94.
69. PAO, C. C., LIN, S-S., LIN, C-Y., MAA, J-S., LAI, C-H. & HSIEH, T-T. (1991). Identification of human papillomavirus DNA sequences in peripheral blood mononuclear cells. American Journal of Clinical Pathology 95, 540-6.
70. PEI, D. & SHI, C. (1990). Transcriptional activation and repression by cellular DNA binding protein C/EBP. Journal of Virology 64, 1517-22.
71. PENNIE, W. D. & CAMPO, M. S. (1992). Synergism between bovine papillomavirus type 4 and the flavonoid quercetin in cell transformation in vitro. Virology 190, 861-5.
72. PENNIE, W. D., GRINDLAY, G. J., CAIRNEY, M. & CAMPO, M. S. (1993). Analysis of the transforming functions of bovine papillomavirus type 4. Virology 193, 614-20.
73. PETTI, L. & DIMAIO, D. (1994). Specific interaction between the bovine papillomavirus E5 transforming protein and the β-receptor for platelet derived growth factor in stably transformed and acutely transfected cells. Journal of Virology 68, 3582-92.
74. PFISTER, H., GASSENMAIER, A., NURNBERGER, F. & STUTTGEN, G. (1983). Human papillomavirus 5 DNA in carcinoma of an epidermodysplasia verruciformis patient infected with various human papillomavirus types. Cancer Research 43, 1436-41.
75. PLOWRIGHT, W., LINSELL, C. A. & PEERS, F. G. (1971). A focus of rumenal cancer in Kenyan cattle. British Journal of Cancer 25, 72-80.
76. SCHILLER, J. T. & RODEN, R. B. S. (1995). Papillomavirus-like particles. Papillomavirus Report 6, 121-8.
77. SCHWARZ, E., FREESE, U. K., GISSMANN, L., MAYER, W., ROGGENBUCK, B., STREMLAU, A. & ZUR HAUSEN, (1985). Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314, 111-4.
78. SCOBIE, L. (1996). The role of p53 in cell transformation by BPV-4. Phd Thesis, University of Glasgow, UK.
79. SCOBIE, L., JACKSON, M. E. & CAMPO M. S. (1997). The role of exogeneous p53 and E6 oncoproteins in in vitro Transformation by bovine papillomavirus Type 4 (BPV-4): Significance of the absence of au E6 ORF in the BPV-4 genome. Journal of General Virology 78, in press.
80. SHERR, C. J. (1994). The ins and outs of Rb: coupling gene expression to the cell cycle clock. Trends in Cell Biology 4, 15-18.
81. SHINDOH, M., CHIBA, I., YASUDA, M., SAITO, T., FUNAOKA, K., KOHGO, T., AMEMIYA, A., SAWADA, Y. & FUJINAGA, K. (1995). Detection of human papillomavirus DNA sequences in oral squamous cell carcinomas and their relation to p53 and proliferating cell nuclear antigen expression. Cancer 1, 1513-21.
82. SIBBET, G. J., CUTHILL, S. & CAMPO, M. S. (1995). The enhancer in the long control region of human papillomavirus type 16 is up-regulated by PEF-1 and down-regulated by Oct-1. Journal of Virology 69, 4006-11.
83. SIEGSMUND, M., WAYSS, & AMTMANN, E. (1991). Activation of latent papillomavirus genomes by chronic mechanical irritation. Journal of General Virology 72, 2787-9.
84. SMITH, K. T. & CAMPO, M. S. (1988). "Hit and run" transformation of mouse C127 cells by bovine papillomavirus type 4: the viral DNA is required for the initiation but not for maintenance of the transformed phenotype. Virology 164, 39-47.
85. STRAIGHT, S. W., HERMAN, B. & MCCANCE, D. J. (1995). The E5 oncoprotein of human papillomavirus type 16 inhibits the acidification of endosomes in human keratinocytes. Journal of Virology 69, 3185-92.
86. THIERRY, F. & YANIV, M. (1987). The BPV1-E2 transacting protein can be either an activator or a repressor of the HPV18 regulatory region. EMBO Journal 6, 3391-7.
87. CDK2 and cyclin A. Oncogene 8, 195-202.
88. VOUSDEN, K. H. (1994). Mechanisms of transformation by HPV. In Human papillomavirus and cervical cancer, pp. 92-115. eds P. L. Stern and M. A. Stanley. Oxford University Press, Oxford, UK.
89. WATRACH, A. M., SMALL, E. & CASE, M. T. (1970). Canine papilloma: progression of oral papilloma to carcinoma. Journal of the National Cancer Institute 45, 915-20.
90. WHITE, A. E., LIVANOS, E. M. & TLSTY, T. D. (1994). Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins. Genes and Development 8, 666-77.
91. WIENER, J. S., LIU, E. T. & WALTHER, P. J. (1992). Oncogenic human papillomavirus type 16 is associated with squamous cell cancer of the male urethra. Cancer Research 52, 5018-23.
92. YANG, L., LI, R., MOHR, I. J., CLARK, R. & BOTCHAN, M. R. (1991). Activation of BPV1 replication in vitro by the transcription factor E2. Nature 353, 628-32.
93. ZERFASS, K., SCHULZE, Z, SPITKOVSKY, D., FRIEDMAN, V., HENGLEIN, B. & JANSEN-DURR, P. (1995). Sequential activation of cyclin E and cyclin A gene expression by human papillomavirus type 16 E7 through sequences necessary for transformation. Journal of Virology 69, 6389-99.
94. ZHOU, J. & FRAZER, I. H. (1995). Papovaviridiae: Capsid structure and capsid protein function. Papillomavirus Report 6, 59-64.
95. ZUR HAUSEN, H. (1991). Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 184, 9-13.
96. ZUR HAUSEN, H. (1994). Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. In Human Pathogenic Papillomaviruses, Current Topics in Microbiology and Immunology, 186, 131-56.